U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C37H40O9
Molecular Weight 628.7081
Optical Activity ( + )
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RESINIFERATOXIN

SMILES

[H][C@]12O[C@]4(CC3=CC=CC=C3)O[C@]1(C[C@@H](C)[C@]5(O4)[C@]6([H])C=C(C)C(=O)[C@@]6(O)CC(COC(=O)CC7=CC=C(O)C(OC)=C7)=C[C@@]25[H])C(C)=C

InChI

InChIKey=DSDNAKHZNJAGHN-MXTYGGKSSA-N
InChI=1S/C37H40O9/c1-21(2)35-17-23(4)37-27(33(35)44-36(45-35,46-37)19-24-9-7-6-8-10-24)14-26(18-34(41)30(37)13-22(3)32(34)40)20-43-31(39)16-25-11-12-28(38)29(15-25)42-5/h6-15,23,27,30,33,38,41H,1,16-20H2,2-5H3/t23-,27+,30-,33-,34-,35-,36-,37-/m1/s1

HIDE SMILES / InChI

Molecular Formula C37H40O9
Molecular Weight 628.7081
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Resiniferatoxin (RTX or RTX-107) is a vanilloid derived from a cactus-like plant (Euphoria resiniferous) and has anti-inflammatory activity. This compound is an agonist of the transient receptor potential vanilloid 1 (TRPV1). Resiniferatoxin produces analgesia by desensitizing the TRPV1 receptor. Findings of several studies have suggested a potential therapeutic use of the anti-inflammatory effect of resiniferatoxin. Phase I and II clinical trials have been completed or are underway, evaluating the safety and efficacy of resiniferatoxin in pain-related disorders such as osteoarthritis and cancers.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Effect of resiniferatoxin on the isolated rabbit iris sphincter muscle: comparison with capsaicin and bradykinin.
1992 Mar 24
Regulation of neuropeptide release from pulmonary capsaicin-sensitive afferents in relation to bronchoconstriction.
1993
Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity.
1998 Mar
Analysis of the native quaternary structure of vanilloid receptor 1.
2001 Jul 27
High affinity antagonists of the vanilloid receptor.
2002 Oct
Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats.
2003 May
Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages.
2003 Nov
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis.
2004 Dec 15
Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders.
2004 Jul
Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves.
2004 Sep 19
Evaluation of the anti-emetic potential of anti-migraine drugs to prevent resiniferatoxin-induced emesis in Suncus murinus (house musk shrew).
2005 Jan 31
Substantial role of locus coeruleus-noradrenergic activation and capsaicin-insensitive primary afferent fibers in bee venom's anti-inflammatory effect.
2006 Jun
Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes.
2006 Sep
Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.
2007 Jan
TRPV1 is a novel target for omega-3 polyunsaturated fatty acids.
2007 Jan 15
Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats.
2007 Jul
Role of capsaicin-sensitive afferents and sensory neuropeptides in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity in the mouse.
2007 Jun 7
Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat.
2007 Sep
Human keratinocytes are vanilloid resistant.
2008
Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy.
2008 Feb
Preventive effect of TRPV1 agonists capsaicin and resiniferatoxin on ischemia/reperfusion-induced renal injury in rats.
2008 May
Regulation of the benzamil-insensitive salt taste receptor by intracellular Ca2+, protein kinase C, and calcineurin.
2009 Sep
Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat.
2010 Feb
Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.
2011 Dec 1
Resiniferatoxin induces death of bladder cancer cells associated with mitochondrial dysfunction and reduces tumor growth in a xenograft mouse model.
2014 Dec 5
Substance Class Chemical
Created
by admin
on Sat Dec 16 14:32:06 UTC 2023
Edited
by admin
on Sat Dec 16 14:32:06 UTC 2023
Record UNII
A5O6P1UL4I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RESINIFERATOXIN
INN   USAN  
Official Name English
Resiniferatoxin [WHO-DD]
Common Name English
BENZENEACETIC ACID, 4-HYDROXY-3-METHOXY-, ((2S,3AR,3BS,6AR,9AR,9BR,10R,11AR)-3A,3B,6,6A,9A,10,11,11A-OCTAHYDRO-6A-HYDROXY-8,10-DIMETHYL-11A-(1-METHYLETHENYL)-7-OXO-2-(PHENYLMETHYL)-7H-2,9B-EPOXYAZULENO(5,4-E)-1,3-BENZODIOXOL-5-YL)METHYL ESTER
Common Name English
(+)-RESINIFERATOXIN
Common Name English
resiniferatoxin [INN]
Common Name English
RESINIFERATOXIN [USAN]
Common Name English
LOPAIN
Brand Name English
[(2S,3aR,3bS,6aR,9aR,9bR,10R,11aR)-2-Benzyl-6a-hydroxy-8,10-dimethyl-11a-(prop-1-en-2-yl)-7-oxo-3a,6,6a,7,9a,10,11,11a-octahydro-3bH-2,9b-epoxyazuleno[5,4-E]-1,3-benzodioxol-5-yl]methyl 2-(4-hydroxy-3-methoxyphenyl)acetate
Systematic Name English
MTX-071
Common Name English
MTX-71
Code English
Classification Tree Code System Code
NCI_THESAURUS C2198
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
FDA ORPHAN DRUG 164802
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
Code System Code Type Description
CAS
57444-62-9
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
PUBCHEM
5702546
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
USAN
GH-167
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
WIKIPEDIA
RESINIFERATOXIN
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
FDA UNII
A5O6P1UL4I
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
INN
11485
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
CHEBI
8809
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
EPA CompTox
DTXSID00894764
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
NCI_THESAURUS
C1214
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
MESH
C024353
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
SMS_ID
100000175504
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
DRUG BANK
DB06515
Created by admin on Sat Dec 16 14:32:06 UTC 2023 , Edited by admin on Sat Dec 16 14:32:06 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY